A large analysis of health records from 87 health care centers across the United States found that people taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs), particularly fluoxetine, were significantly less likely to die of COVID-19 than a matched control group.
from Latest Science News -- ScienceDaily https://ift.tt/3cjR4Ru
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment